Le Lézard
Classified in: Health, Business
Subject: PER

HealthCombix Expands Healthcare Blockchain Advisory Board


NASHVILLE, Tenn., Oct. 23, 2017 /PRNewswire/ -- HealthCombix, a global decentralized healthcare development company, announced today Mr. Matthew Conboy has joined the company Advisory Board.  

Mr. Conboy is a health care professional with a background in strategy, risk assurance, and technology. Matthew began his career as a health care and financial services consultant at PricewaterhouseCoopers, serving clients in Health Care (including Health Systems and Pharmaceuticals) and Life and Disability Insurance. Matthew is currently a Director of Innovation at CareAllies (a Cigna company), and leads solution development for CareAllies's home-based chronic care management division, Alegis Care. Prior to joining CareAllies, Matthew worked for Cigna's enterprise Strategic Operations team, helping business unit leaders translate enterprise-level strategy into operational plans. In addition, Matthew co-founded Cigna's internal blockchain team, which assesses blockchain-specific opportunities in alignment with Cigna's strategy. Matthew received his MBA from the University of Hartford.

"HealthCombix is excited to have Mathew as an adviser.  Mathew brings an enterprise, risk management, and population health perspective to the team and project.  We look forward to collaborating on envisioning next generation open healthcare ecosystems and networks," says Cyrus Maaghul, CEO of HealthCombix.

HealthCombix combines confidential human data asset management, disease and wellness prediction markets, and the power of open, decentralized payment networks to build future healthcare ecosystems, DAOs, and cooperatives.

Cyrus Maaghul
CEO
HealthCombix
6153107945
[email protected]

This release was issued through WebWire(R). For more information, visit http://www.webwire.com.

SOURCE HealthCombix


These press releases may also interest you

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 19:05
Appili Therapeutics Inc. (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and medical countermeasures, today announced it has secured additional bridge financing in the amount of C$300,000...

at 19:00
David J. Dykeman, co-chair of the Life Sciences & Medical...

at 18:30
Aspire Health Alliance ("Aspire Health") is a company headquartered in Braintree, Massachusetts, that provides behavioral health services in the community.  Aspire Health experienced a data security incident that may have involved personal and...

at 17:21
Chemistree Technology Inc. (US OTC: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the adjourned extraordinary meeting of the holders of the 10% senior unsecured convertible debentures of the Company (the "Debentures") was...

at 17:15
Summary Product: Counterfeit Viagra, 100 mg sildenafil tabletsIssue: Health products - Product safety, Unauthorized productWhat to do: Immediately stop using and safely dispose of this product. Consult your health care provider if you have taken this...



News published on and distributed by: